NewGenIvf closes $1.25 million public share offering
NIVF•NewGenIvf closed a public offering raising about $1.25 million in gross proceeds, with net proceeds earmarked for a K25.ai investment, debt restructuring and working capital.
1. Offering details
The reasonable best-efforts offering included 17,857,143 Class A ordinary shares or pre-funded warrants, including 125,000 shares. Shares were priced at $0.07 each and pre-funded warrants at $0.06999 each, with a $0.00001 exercise price; the warrants are immediately exercisable and remain exercisable until fully exercised. The offering closed on Sept. 30, 2026.
